Mid-size Biotech Archemix is a small to mid-sized biotechnology research company with 11-50 employees and a revenue range of 10M to 25M, indicating growing scale potential for partnerships and enterprise deals with mid-market life sciences vendors.

US Market Presence Based in the United States, Archemix represents a domestic customer profile that could be prioritized for regional sales motions, facilitating easier regulatory alignment, on-site demonstrations, and faster procurement cycles.

Tech Stack Utilize The company’s web and software stack (WordPress, MySQL, PHP, Apache, jQuery, undress) suggests standard IT infrastructure and potential needs for cloud, data management, security, or integration services to support R&D operations and collaboration tools.

Strategic Fit Opportunities Given revenue size and peer group benchmarks with Regulus Therapeutics and similar scale peers, there is an opportunity to cross-sell capabilities in research tools, analytical services, or collaboration platforms aimed at accelerating biotech R&D.

Growth Signals The presence of a defined funding range and a professional growth footprint implies openness to supplier partnerships, contract research, or technology licenses that support early-stage to mid-stage biotech development and scalability initiatives.